Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design

The surface of enveloped viruses can be extensively glycosylated. Unlike the glycans coating pathogens such as bacteria and fungi, glycans on viruses are added and processed by the host-cell during biosynthesis. Glycoproteins are typically subjected to α-mannosidase processing and Golgi-mediated gly...

Description complète

Détails bibliographiques
Auteurs principaux: Crispin, M, Doores, K
Format: Journal article
Langue:English
Publié: Elsevier 2015
_version_ 1826293690232995840
author Crispin, M
Doores, K
author_facet Crispin, M
Doores, K
author_sort Crispin, M
collection OXFORD
description The surface of enveloped viruses can be extensively glycosylated. Unlike the glycans coating pathogens such as bacteria and fungi, glycans on viruses are added and processed by the host-cell during biosynthesis. Glycoproteins are typically subjected to α-mannosidase processing and Golgi-mediated glycosyltransferase extension to form complex-type glycans. In envelope viruses, exceptions to this default pathway are common and lead to the presence of oligomannose-type glycan structures on the virion surface. In one extreme example, HIV-1 utilises a high density of glycans to limit host antibody recognition of protein. However, the high density limits glycan processing and the resulting oligomannose structures can be recognised by broadly neutralising antibodies isolated from HIV-1 infected patients. Here we discuss how divergence from host-cell glycosylation can be targeted for vaccine design.
first_indexed 2024-03-07T03:34:02Z
format Journal article
id oxford-uuid:bbb0682d-cb3b-410a-83e0-71d25e963de8
institution University of Oxford
language English
last_indexed 2024-03-07T03:34:02Z
publishDate 2015
publisher Elsevier
record_format dspace
spelling oxford-uuid:bbb0682d-cb3b-410a-83e0-71d25e963de82022-03-27T05:18:48ZTargeting host-derived glycans on enveloped viruses for antibody-based vaccine designJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:bbb0682d-cb3b-410a-83e0-71d25e963de8EnglishSymplectic Elements at OxfordElsevier2015Crispin, MDoores, KThe surface of enveloped viruses can be extensively glycosylated. Unlike the glycans coating pathogens such as bacteria and fungi, glycans on viruses are added and processed by the host-cell during biosynthesis. Glycoproteins are typically subjected to α-mannosidase processing and Golgi-mediated glycosyltransferase extension to form complex-type glycans. In envelope viruses, exceptions to this default pathway are common and lead to the presence of oligomannose-type glycan structures on the virion surface. In one extreme example, HIV-1 utilises a high density of glycans to limit host antibody recognition of protein. However, the high density limits glycan processing and the resulting oligomannose structures can be recognised by broadly neutralising antibodies isolated from HIV-1 infected patients. Here we discuss how divergence from host-cell glycosylation can be targeted for vaccine design.
spellingShingle Crispin, M
Doores, K
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
title Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
title_full Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
title_fullStr Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
title_full_unstemmed Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
title_short Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
title_sort targeting host derived glycans on enveloped viruses for antibody based vaccine design
work_keys_str_mv AT crispinm targetinghostderivedglycansonenvelopedvirusesforantibodybasedvaccinedesign
AT dooresk targetinghostderivedglycansonenvelopedvirusesforantibodybasedvaccinedesign